Tag: cell-based therapy

October 11, 2018

Vital Therapies Provides Strategic Update

Vital Therapies (Nasdaq:VTL), a biotherapeutic company that has been developing ELAD, a cell-based therapy targeting the treatment of liver failure,...
September 12, 2018

Vital Therapies Announces That Topline Results of VTL-308 Fail to Achieve Primary and Secondary Endpoints of Improvement in Survival

Vital Therapies (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure,...